BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:52 PM
 | 
May 10, 2010
 |  BC Extra  |  Company News

bioMerieux, GSK to develop cancer diagnostic

bioMerieux S.A. (Euronext:BIM) partnered with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to develop a diagnostic for use with two of GSK's cancer compounds. The...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >